Notable
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Primary completion pushed from Jun 2026 to Mar 2028
Also in this update: Study completion pushed from Dec 2026 to Jun 2028
Eleison Pharmaceuticals LLC.Phase 3 NCT01954992 Registry history of NCT01954992 on ClinicalTrials.gov (opens the registry)